Dawit R, Goedel WC, Chang HY, Nunn AS, Chan PA, Doshi JA, Dean LT County-level factors associated with reversal of insurer-approved HIV pre-exposure prophylaxis prescriptions in the United States, 2018 , AIDS and Behavior: 2024

Shafrin J, Kim J, Cohen JT, Garrison LP, Goldman DA, Doshi JA, Krieger J, Lakdawalla DN, Neumann PJ, Phelps CE, Whittington MD, Willke R "Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices" , Forum Health Econ Policy, 27(1): 2024,29-116

Bakre S, Chang H, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT "Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments" , JAMA Internal Medicine, 184(10): 2024,1204-1211

Klebanoff MJ, Li P, Chatterjee P, Doshi JA "Real-Time Prescription Benefit Tool Adoption Among US Hospitals" , JAMA Health Forum, 5(10): 2024,e243181

Klebanoff MJ, Li P, Lin JK, Doshi JA "Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans" , JAMA, 332(1): 2024,74-76

Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF "Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting" , Clinical Lymphoma, Myeloma, and Leukemia, 24(5): 2024,e181-e190

Doshi JA, Li P, Geng Z, Seo S, Patel C, Benson C "Out-of-Pocket Costs for Long-Acting Injectable and Oral Antipsychotics Among Medicare Patients With Schizophrenia" , Psychiatric Services, 75(4): 2024,333-341

Dean L, Nunn AS, Chang HY, Goedel WC, Chan PA, Doshi JA "Estimating the Impact of Out-of-Pocket Cost Changes on the Abandonment of HIV Pre-exposure Prophylaxis (PrEP) Prescriptions" , Health Affairs, 43(1): 2024,36-45

Dawit R, Goedel WC, Reid SC, Doshi JA, Nunn AS, Chan PA, Dean LT "Geographic Variation of PrEP Reversal and Abandonment across the United States" , AIDS, 38(4): 2024,557-566

Li P, Prajapati G, Geng Z, Ladage V, Arduino JM, Watson D, Gross R, Doshi JA "Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program" , AIDS and Behavior, 28(3): 2024,1002-1014